Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-134-VI | BMS-265246 | 3.16227766017 | 0.1375 | -0.02611 |
| MDA-MB-134-VI | BMS-265246 | 3.16227766017 | 0.3286 | -0.00105 |
| MDA-MB-134-VI | BMS-265246 | 3.16227766017 | 0.91225 | |
| MDA-MB-436 | RO-3306 | 3.16227766017 | 0.9726 | 0.01447 |
| HCC1395 | RO-3306 | 3.16227766017 | -0.0024 | 0.07598 |
| HCC1395 | RO-3306 | 3.16227766017 | 0.1602 | 0.02492 |
| HCC1395 | RO-3306 | 3.16227766017 | 0.3649 | 0.03686 |
| MDA-MB-436 | RO-3306 | 3.16227766017 | 0.8723 | 0.01075 |
| MDA-MB-436 | RO-3306 | 3.16227766017 | 0.7458 | -0.02257 |
| CAL-85-1 | BMS-265246 | 3.16227766017 | 0.0090 | 0.03802 |
| CAL-85-1 | BMS-265246 | 3.16227766017 | 0.0138 | 0.06224 |
| CAL-85-1 | BMS-265246 | 3.16227766017 | 0.0515 | 0.03422 |
| HCC1395 | Rucaparib | 3.16227766017 | 0.4067 | 0.01763 |